[Changes in the concentration of hematopoietic stem cells, erythrocytes and leukocytes during hepatoma development and in exposure to an antitumor agent].
D000818:Animals; D001772:Blood Cell Count; D001853:Bone Marrow / Q000473:pathology; D003114:Colony-Forming Units Assay; D003979:Diazonium Compounds / Q000627:therapeutic use*; D004912:Erythrocytes / Q000187:drug effects / Q000473:pathology*; D005260:Female; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000473:pathology*; D007700:Kinetics; D007962:Leukocytes / Q000187:drug effects / Q000473:pathology*; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy / Q000473:pathology*; D051379:Mice; D008809:Mice, Inbred C3H; D009368:Neoplasm Transplantation; D013386:Succinates / Q000627:therapeutic use*
D003979:Diazonium Compounds; D013386:Succinates; C000279:diazan
Izmenenie kontsentratsii stvolovykh krovetvornykh kletok, éritrotsitov e leíkotsitov pri razvitii gepatomy i pri vozdeĭstvii protivoopukholevym sredstvom.